# US 2026/0234644 A1 · Systems and methods for scalable transfection reagent preparation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0234644 A1
- Document ID: US20260234644A1
- Status: Published application
- Kind: A1
- Application number: 19/152,683
- Filed: 2024-01-16
- Published: 2026-08-13
- Earliest claimed: 2023-01-31
- Assignees: Corning Incorporated
- Applicants: Corning Incorporated
- Inventors: John Fitzpatrick; Vasiliy Nikolaevich Goral
- Web page: https://patentgrep.com/patent/US20260234644A1

## CPC

- C12M 23/58: {Reaction vessels connected in series or in parallel (combinations of bioreactors with other apparatus, C12M43/00)}
- C12N 15/64: General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
- B01F 33/30: Micromixers
- C12M 23/16: {Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093)}
- C12M 29/10: {Perfusion}
- C12M 43/00: {Combinations of bioreactors or fermenters with other apparatus}
- C12N 15/87: Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- A61K 48/0091: {Purification or manufacturing processes for gene therapy compositions}
- C12N 2750/14143: viral genome or elements thereof as genetic vector
- C12N 2750/14152: relating to complementing cells and packaging systems for producing virus or viral particles
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- B01F: MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING (mixing paints B44D3/06)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Methods and systems are provided for scalable preparation of transfection reagent. A method includes providing a plurality of reagent components for mixing together to form the transfection reagent, and mixing the reagent components in a passive mixing module having an outlet for outputting a mixture of the plurality of reagent components. The method further includes providing a plurality of incubation containers fluidly connected to the outlet and configured for receiving and holding the mixture; filling one or more of the plurality of incubation containers with at least a portion the mixture from the outlet, where the filling occurs consecutively; and holding the at least a portion of the mixture in one or more of the plurality of incubation containers for a predetermined incubation time to form the transfection reagent.

## Claims

### Claim 1

A method for preparing a transfection reagent comprising:
providing a plurality of reagent components for mixing together to form the transfection reagent;
mixing the plurality of reagent components in a passive mixing module comprising a plurality of inlets and an outlet, the plurality of inlets being for receiving the plurality of reagent components and the outlet being for outputting a mixture of the plurality of reagent components;
providing a plurality of incubation containers fluidly connected to the outlet and configured for receiving and holding the mixture;
filling one or more of the plurality of incubation containers with at least a portion the mixture from the outlet, the filling of the one or more of the plurality of incubation containers occurring consecutively;
holding the at least a portion of the mixture in one or more of the plurality of incubation containers for a predetermined incubation time to form the transfection reagent.

### Claim 2 (depends on 1)

The method of claim 1, further comprising:
removing the at least a portion of the mixture from the one or more of the plurality of incubation containers after the predetermined incubation time.

### Claim 3 (depends on 2)

The method of claim 2, wherein the removing is performed for each of the one or more of the plurality of incubation containers consecutively.

### Claim 4 (depends on 3)

The method of claim 3, wherein the removing is performed consecutively based on when the predetermined incubation time for each of the one or more plurality of incubation containers is reached.

### Claim 5 (depends on 1)

The method of claim 1, wherein the predetermined incubation time is based on a desired size of nanoparticle complexes in the transfection reagent.

### Claim 6 (depends on 1)

The method of claim 1, further comprising, after the transfection reagent is formed, washing at least one of the passive mixing module, the plurality of incubation containers, and any tubing, valves, or pumps with a liquid media to remove any remaining transfection reagent.

### Claim 7

(canceled)

### Claim 8 (depends on 1)

The method of claim 1, wherein the passive mixing module comprises a microfluidic mixing device.

### Claim 9 (depends on 8)

The method of claim 8, wherein the microfluidic mixing device comprises a plurality of mixing elements.

### Claim 10 (depends on 9)

The method of claim 9, wherein the plurality of mixing elements comprises heart-shaped mixing elements.

### Claim 11 (depends on 8)

The method of claim 8, wherein the microfluidic mixing device comprises a continuous microfluidic flow reactor.

### Claim 12 (depends on 11)

The method of claim 11, wherein the continuous microfluidic flow reactor is configured for scale-up from lab bench to industrial manufacturing.

### Claim 13 (depends on 1)

The method of claim 1, wherein the transfection reagent comprises polyethylenimine (PEI), calcium phosphate, DEAE-Dextran, polyarginine, dendrimers, ionizable or cationic lipids, lipid-like lipidoids, plasmids or combinations thereof.

### Claim 14 (depends on 1)

The method of claim 1, wherein the method further comprises transfecting cells using the transfection reagent.

### Claim 15 (depends on 1)

The method of claim 1, further comprising flowing the transfection reagent to a culture vessel.

### Claim 16 (depends on 15)

The method of claim 15, wherein the culture vessel comprises a bioreactor.

### Claim 17 (depends on 15)

The method of claim 15, wherein the culture vessel comprises a perfusion bioreactor.

### Claim 18

(canceled)

### Claim 19 (depends on 15)

The method of claim 15, wherein the culture vessel comprises cells to be transfected.

### Claim 20 (depends on 15)

The method of claim 15, wherein the culture vessel comprises culture medium.

### Claim 21 (depends on 1)

The method of claim 1, wherein the mixing module comprises a disposable mixing device.

### Claim 22 (depends on 1)

The method of claim 1, wherein the mixing module comprises a reusable mixing device.
